Collaboration connects internationally recognized cancer multi-omics research with HanchorBio's clinical-stage immuno-oncology platform to accelerate biomarker-driven drug development and strengthen next-generation precision immunotherapy TAIPEI and SHANGHAI and SAN FRANCISCO, Aug. 9,...